- BrandNEXTGEN BIOTECH
Mabthera Generic Content- Rituximab, Manufactured By:F.Hoffmann-La Roche Ltd, Switzerland
Mabthera infusion is a type of medicine known as a monoclonal antibody. It works by attacking white blood cells called B cells. This action means it can be used to treat two different diseases: cancers of the lymphatic system known as non-Hodgkins lymphomas, and the inflammatory disease of the joints known as rheumatoid arthritis.
Available As: 500Mg & 100Mg